ReGelTec, a medical device company out of Baltimore’s leading medical device HYDRAFIL, has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA). The Breakthrough Device Program was created with intentions to expedite the process in which patients gain access to technologies that could reverse debilitating conditions. The device made for the treatment of lower back pain has been tested in Barranquilla, Colombia, and is receiving grants to continue on its clinical development journey.
Read more here.
More on: News Regulatory